Drug Alcohol Depend by Prybylski, Dimitri et al.
Diverse HIV epidemics among people who inject drugs in 
Thailand: Evidence from respondent-driven sampling surveys in 
Bangkok and Chiang Mai☆
Dimitri Prybylskia,b,*, Chomnad Manopaiboona, Prin Visavakuma, Kovit Yongvanitjitc, 
Apinun Aramrattanad, Parnrudee Manomaipiboonc, Suvimon Tanpradecha, Orapin 
Suksripanicha, Sarika Pattanasina, Mitchell Wolfea,b, and Sara J. Whiteheada,b
aThailand MOPH – U.S. CDC Collaboration, Nonthaburi 11000, Thailand bDivision of Global HIV/
AIDS, Centers for Disease Control and Prevention, Atlanta, 30333, USA cBangkok Metropolitan 
Administration, Bangkok 10200, Thailand dResearch Institute for Health Sciences, Chiang Mai, 
Thailand
Abstract
Background—Thailand’s long-standing HIV sero-sentinel surveillance system for people who 
inject drugs (PWID) is confined to those in methadone-based drug treatment clinics and 
representative data are scarce, especially outside of Bangkok.
Methods—We conducted probability-based respondent-driven sampling (RDS) surveys in 
Bangkok (n = 738) and Chiang Mai (n = 309) to increase understanding of local HIV epidemics 
and to better inform the planning of evidence-based interventions.
Results—PWID had different epidemiological profiles in these two cities. Overall HIV 
prevalence was higher in Bangkok (23.6% vs. 10.9%, p < 0.001) but PWID in Bangkok are older 
and appear to have long-standing HIV infections. In Chiang Mai, HIV infections appear to be 
more recently acquired and PWID were younger and had higher levels of recent injecting and 
sexual risk behaviors with lower levels of intervention exposure. Methamphetamine was the 
predominant drug injected in both sites and polydrug use was common although levels and 
patterns of the specific drugs injected varied significantly between the sites. In multivariate 
analysis, recent midazolam injection was significantly associated with HIV infection in Chiang 
Mai (adjusted odds ratio = 8.1; 95% confidence interval: 1.2–54.5) whereas in Bangkok HIV 
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status was not associated with recent risk behaviors as infections had likely been acquired in the 
past.
Conclusion—PWID epidemics in Thailand are heterogeneous and driven by local factors. There 
is a need to customize intervention strategies for PWID in different settings and to integrate 
population-based survey methods such as RDS into routine surveillance to monitor the national 
response.
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1. Introduction
Since the late 1980s, people who inject drugs (PWID) have been tracked as a key population 
in annual national HIV sentinel surveillance prevalence surveys conducted by the Thailand 
Ministry of Public Health (MOPH). These surveys have shown that HIV seroprevalence 
remained high at 30–50% over the last two decades (Brown et al., 1994; Thai National 
AIDS Committee, 2014). However, participants in these surveys have been recruited 
exclusively from drug treatment centers where the main service is methadone treatment for 
opiate users.
Studies among PWID in Thailand have been conducted mainly in Bangkok and have 
typically recruited participants enrolled in clinical trials (Martin et al., 2010; Pitisuttithum et 
al., 2006; van Griensven et al., 2005; Vanichseni et al., 2001) or from studies that used 
convenience-based sampling methods (Fairbairn et al., 2009; Hayashi et al., 2011; Kerr et 
al., 2009, 2010; Werb et al., 2009). Few community-based epidemiological studies have 
used methods appropriate to obtain data on representative samples of PWID such as 
respondent-driven sampling (RDS; Heckathorn, 1997, 2002; Johnston et al., 2010, Magnani 
et al., 2005). This situation exists despite the international recommendation to routinely 
implement such surveys among PWID populations (World Health Organization, 2012). An 
RDS survey was conducted in Bangkok in 2003–2004 but did not measure HIV 
seroprevalence and was carried out during an anti-drug campaign, commonly referred to as 
the “war on drugs”, that likely resulted in under-recruitment of out-of-treatment PWID 
(Wattana et al., 2007).
In Thailand, there has been a shift in the observed pattern of injection drug use away from 
heroin, which was the predominant drug during the 1980–1990s (Vanichseni et al., 2001; 
Weniger et al., 1991), to methamphetamine and midazolam (a short-acting benzodiazepine; 
Hayashi et al., 2011; Martin et al., 2010; van Griensven et al., 2005; Vongchak et al., 2005; 
Werb et al., 2009). The “war on drugs” in Thailand was launched in 2003 and the resulting 
intensified drug law enforcement, the declining demand and increased price of heroin all 
likely contributed to this trend (van Griensven et al., 2005; Vongchak et al., 2005). The shift 
away from heroin use over time has compromised the usefulness of surveillance data 
collected from methadone treatment clinics. For example, there is a lack of systematic data 
from both methamphetamine and midazolam injectors despite increasing use of these drugs 
Prybylski et al. Page 2













and the fact that both drugs are associated with increased HIV risk behavior (Fairbairn et al., 
2007; Martin et al., 2010; van Griensven et al., 2005).
Outside Bangkok, epidemiologic data on PWID are even more limited. This is of concern 
because the characteristics and dynamics of HIV epidemics among PWID are often 
localized and heterogeneous (Mathers et al., 2008; Sharma et al., 2009). Chiang Mai is a 
major northern city with documented high HIV prevalence among in-treatment PWID 
(Thailand Ministry of Health, 2009). The city is located near the ‘Golden Triangle’, a major 
source of opium production in the past, and more recently an entry route for both heroin and 
methamphetamine from bordering countries. In the late 1990s, the pattern of drug use in 
Chiang Mai, and Northern Thailand more broadly, has shifted from opiates to 
methamphetamines (Razak et al., 2003). Early after its introduction methamphetamine was 
typically smoked, taken orally or inhaled (UNODC, 2012), but there is evidence that 
injecting is increasing (McKetin et al., 2008).
We conducted community-based RDS surveys in Bangkok and Chiang Mai to help fill gaps 
in the understanding of local HIV epidemics among PWID and to inform the planning of 




RDS is a type of chain-referral sampling designed to sample hard-to-reach populations not 
typically reached through venue-based sampling methods (Heckathorn, 1997, 2002). RDS 
uses a dual system of structured compensation and quota limits on each individual’s ability 
to recruit members of their social network to reduce biases associated with other chain-
referral methods. An initially selected group of participants (“seeds”) are purposively 
recruited who in turn recruit and refer their peers, continuing in multiple ‘waves’ of 
recruitment. At both locations in this study, seeds were selected by study investigators and 
clinic staff, with careful attention to diversities such as sex, type of drug use, and age.
2.2. RDS sites
In Bangkok, we used the office of a non-governmental organization, O-zone, as the site 
where we implemented RDS. O-zone has extensive experience working with the drug user 
population in Bangkok, including conducting outreach, education, and prevention with drug 
users. In Chiang Mai, the survey site was an office of the Research Institute for Health 
Sciences (RIHES) which was used for a concurrent intervention trial with PWID. Both sites 
were in accessible neighborhoods that include private rooms for interviewing, counseling 
and specimen collection.
2.3. Inclusion criteria
Eligible PWID were 18 years old or older who injected illicit drugs in the last six months 
and were able and agreed to provide informed consent. Recruited participants in Bangkok 
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and Chiang Mai must have been living or working in the respective cities at the time of the 
survey and in possession of a valid referral coupon.
2.4. Survey procedures
Cross-sectional RDS surveys were conducted in Bangkok and Chiang Mai during March to 
October, 2009. Eligibility was assessed by trained survey staff in the nongovernmental 
survey sites (see Section 2.3) and participants were asked to show injection marks and were 
administered a list of screening questions to confirm that they met the PWID inclusion 
criteria. Consenting participants completed a survey questionnaire administered by 
interviewers, who were trained to make participants feel comfortable during the interview 
process and elicit and record accurate information, and resulting data were entered into 
handheld personal digital assistants (PDAs). Participants also provided blood specimens for 
on-site rapid HIV testing (Determine HIV-1/2 Abbott Japan Ltd, Tokyo, Japan). Two 
confirmatory tests were conducted for those screening HIV-positive according to the MOPH 
national laboratory testing guidelines (Thailand Ministry of Public Health, 2011). HIV-
positive participants were referred for care at local public facilities and CD4 count testing 
was provided at no cost. Participants were given not more than three coupons to recruit their 
peers. They received compensation of 400 Thai Baht (USD 11.5) for their time in 
completing the questionnaire and serological specimen collection and 80 Thai Baht (USD 
2.3) for each recruited peer up to a maximum of 240 Thai Baht (USD 6.9) for three peers.
2.5. Data management and analysis
Questionnaire data from the handheld PDAs was synched to a Microsoft Access database 
and linked and merged with laboratory data using a confidential 17-digit coupon ID number. 
Respondent-Driven Sampling Analysis Tool (RDSAT) Version 6.0.1 (Cornell University, 
NY, USA) was used to generate univariate estimates of key variables that were weighted by 
network size and recruitment patterns. A design effect of 2.0 was used in RDSAT to account 
for potential clustering among recruits (Volz et al., 2009). RDSAT-generated weights data 
were exported to STATA 11.0 (College Station, Texas, USA) for bivariate analysis of 
variables (i.e., sociodemographics, injecting and sexual risk behaviors, exposure to HIV 
interventions, and HIV infection status) comparing participants in Bangkok with those in 
Chiang Mai. The Marascuilo procedure was used to calculate p-values for inter-city 
comparison estimates using standard errors adjusted with RDSAT (Marascuilo, 1966). 
Characteristics that could not be assessed by RDSAT were tested crudely using the Pearson 
chi-square test or Fisher Exact test as appropriate. In addition, bivariate analyses were 
conducted to examine factors associated with HIV infection in both cities. Probabilities were 
calculated by Z tests and adjusted odds ratios (AORs) and 95% confidence intervals (95% 
CIs) were generated. All statistical testing was two-tailed and a p-value <0.05 was 
considered statistically significant. Weighted data in STATA software were also used to 
conduct multiple logistic regression modeling to identify factors associated with HIV 
prevalence in both Bangkok and Chiang Mai. Only variables that were associated at a level 
of p ≤ 0.10 in bivariate analysis were entered into the multivariate models to determine 
factors that were independently associated with HIV infection at p < 0.05.
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No personal identifying data were collected as part of this study. All records and specimens 
were labeled using the coupon ID number. The survey was approved by the Ethical Review 
Committee, Thailand MOPH, and the Institutional Review Board, Centers for Disease 
Control and Prevention, Atlanta, USA.
3. Results
3.1. RDS seeds and survey flow
In Bangkok, ten seeds were purposively selected to initiate peer recruitment into the survey, 
six were men, three were less than 30 years of age and five were currently in methadone 
treatment. Eight of the ten seeds successfully recruited peers and among these eight seeds 
the number of propagated recruitment waves ranged from 2 to 15 per seed. A total of 808 
individuals including seeds were screened for eligibility. Of these, 738 (91.3%) PWID met 
the eligibility criteria and agreed to participate in the survey.
Of the eight seeds selected in Chiang Mai, six were men, three were less than 30 years of 
age and three were undergoing treatment at a methadone treatment clinic. All eight seeds 
successfully recruited peers and the number of propagated recruitment waves per seed 
ranged from 2 to 17. A total of 397 individuals were screened and 309 (77.8%) eligible 
PWID agreed to participate.
3.2. Sociodemographic characteristics of participants
The characteristics of survey participants in the two cities are presented in Table 1. Over 
four-fifths of participants in both Bangkok and Chiang Mai were men; participants in 
Chiang Mai were much younger, less likely to be unemployed, and reported a lower 
monthly income. Similar proportions of participants reported being held in prison in the last 
12 months, but Bangkok participants were more likely to have been detained in a police 
holding cell.
3.3. Injecting drug use behaviors
3.3.1. General drug use—Participants drug use behaviors are shown in Table 1. A higher 
proportion of participants in Bangkok reported injecting drugs in the last month than in 
Chiang Mai. Of those who reported injecting drugs in the last month, over twice the 
proportion of participants reported injecting multiple drugs in Bangkok than in Chiang Mai.
Reflecting the younger age of participants in Chiang Mai, participants in this city were nine 
times as likely to report that they first started injecting drugs in the last two years as those in 
Bangkok. Chiang Mai participants were also much more likely to report sharing needles 
during the last 6 months and during their last injection.
3.3.2. Heroin injecting drug use—Approximately one-third of participants reported 
injecting heroin in the last month in both cities. Among those who injected heroin in the last 
month, participants in Bangkok were more than twice as likely to inject one or more other 
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drugs as participants in Chiang Mai. Approximately one-third of heroin injectors reported 
injecting heroin at least daily within the last month in both cities.
3.3.3. Methamphetamine injecting drug use—Twice as many participants in 
Bangkok reported injecting methamphetamine in the last month as in Chiang Mai. Among 
those who injected methamphetamine in the last month, comparable proportions in both 
cities reported injecting at least one other type of drug. A higher proportion of participants in 
Bangkok reported injecting methamphetamine at least daily within the last month than in 
Chiang Mai.
3.3.4. Midazolam injecting drug use—Participants in Bangkok were more than ten 
times as likely (42.2%) to report having injected midazolam in the last month as in Chiang 
Mai (4.0%). Among those who injected midazolam in the last month, 86.0% and 70.8% of 
participants in Bangkok and Chiang Mai respectively reported injecting at least one other 
type of drug and injecting midazolam at least daily within the last month.
3.3.5. Opium injecting drug use—The prevalence of opium injection in the last month 
was low in both cities but higher in Chiang Mai. Cell sizes were too small to do meaningful 
statistical analyses for other opium-injecting characteristics.
3.3.6. Methadone injecting drug use—The prevalence of methadone injection in the 
last month was higher in Bangkok than Chiang Mai. Among those who injected methadone 
in the last month, comparable and high proportions of participants in Bangkok and Chiang 
Mai reported injecting at least one other type of drug.
3.4. Sexual risk behaviors
In both cities slightly less than half of participants reported having had sex with a regular 
partner in the last month, with only about one-fifth reporting condom use during their last 
sex with a regular partner (Table 2). Compared to their Bangkok counterparts, a higher 
proportion of Chiang Mai participants reported casual and commercial sex partners in the 
last month. Participants in Chiang Mai were also less likely to use condoms during last sex 
with both casual and commercial partners and were also more likely to report multiple sex 
partners in the last month.
There was substantial overlap of injecting and sexual risk behaviors in both cities, with 
approximately one-fifth of participants reporting at least one sex partner in the last month 
who injected drugs. Over one-third of participants in Chiang Mai reported both sharing 
injection needles and not using a condom during last sex and this figure (34.1%) was six 
times as high as the corresponding proportion (5.7%) in Bangkok. Among male participants, 
a higher proportion of participants in Chiang Mai (13.7%) than in Bangkok (4.5%) reported 
having sex with another man in the last six months. The sample size was too small to assess 
condom use with male partners.
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3.5. Exposure to HIV prevention interventions
Participants in Chiang Mai reported lower levels of HIV testing than participants in 
Bangkok (Table 2). Only one-fifth of Chiang Mai participants received HIV testing with 
results in the last six months, compared to nearly sixty percent of Bangkok participants. 
Participants in Chiang Mai were also less likely to have been in drug treatment than 
participants in Bangkok (Table 3). While there were no peer outreach services available in 
Chiang Mai at the time of the survey, over 40% of participants in Bangkok reported access 
to peer outreach interventions in the last three months.
3.6. HIV prevalence
HIV prevalence was higher among participants in Bangkok than among participants in 
Chiang Mai (23.6% vs. 10.8%, p < 0.001).
3.6.1. Factors associated with HIV infection in Bangkok—Among Bangkok 
participants the following variables were associated with HIV infection in bivariate analysis 
(Table 3): having ever been in drug treatment, having used a condom during last sex with 
any partner and, having had an HIV test with test results in the last 6 months. In multivariate 
analysis, having ever been in drug treatment (AOR = 3.9, 95%CI: 1.4–9.7) and having had 
an HIV test with test results in the last 6 months (AOR = 0.2; 95%CI: 0.1–0.4) were the only 
significant independent factors associated with HIV prevalence.
3.6.2. Factors associated with HIV infection in Chiang Mai—In Chiang Mai, HIV 
prevalence was higher among participants who reported injecting drugs in the last month 
(15.7% vs. 1.2%, p < 0.01) and among participants who injected multiple drugs (34.5% vs. 
10.4%, p < 0.001) in bivariate analysis (Table 3). HIV infection was also higher among 
participants who injected methamphetamine, midazolam or methadone in the last month. In 
multivariate analysis the only factor that was significantly associated with HIV infection 
was injecting midazolam in the last month (AOR = 8.1, 95% CI: 1.2–54.5).
4. Discussion
These RDS surveys are the first to our knowledge to measure HIV prevalence among 
representative community-based samples of PWID in Thailand. Findings indicate that PWID 
in Bangkok and Chiang Mai have markedly different epidemiological profiles. Participants 
in Chiang Mai were younger, poorer, had higher levels of recent injecting and sexual risk 
behaviors, with less exposure to risk reduction interventions such as contact with peer 
outreach workers, HIV testing and counseling or drug treatment.
While overall HIV prevalence was significantly higher among PWID in Bangkok than in 
Chiang Mai, HIV infections in Bangkok appear to be largely long-standing infections 
concentrated among older PWID who have been injecting drugs for many years. This 
corroborates previous results from Bangkok-based clinical trials but among a more 
representative sample of PWID (Martin et al., 2011; van Griensven et al., 2005). Indeed, 
HIV infection in Bangkok was not significantly associated with recent injecting risk 
behavior, which also suggests that these infections were acquired in the more distant past. In 
Bangkok, PWID who had a history of drug treatment were more likely to be HIV infected. 
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This is likely explained by the fact that the same illegal behaviors that led to increased risk 
of being detained in drug treatment (such as congregating with other PWID in public places 
and sharing needles) are risk factors for acquiring HIV. Similarly, the negative association 
between HIV infection and recent HIV testing is also likely explained by the fact that PWID 
who were HIV-infected in the past would not be expected to seek recent HIV-testing due to 
their awareness of their HIV-positive status. Historically, HIV testing has been mandatory in 
many drug treatment centers in Thailand and this involuntary HIV testing policy continues 
to pose an ethical dilemma. While knowledge of HIV status allows for potential linkage to 
HIV care and treatment services, HIV testing services should be voluntary. This finding 
further indicates that HIV prevalence estimated on the basis of PWID accessing methadone 
clinics may be biased in that HIV-infected PWID are more likely to be sampled than PWID 
in the general population, highlighting the importance of conducting representative 
community-based surveillance. We found that less than one-third of PWID in Bangkok were 
currently in drug treatment, a dramatic decline from two-thirds or higher reported in 
previous studies (Choopanya et al., 2013; Martin et al., 2011; Pitisuttithum et al., 2006; van 
Griensven et al., 2005; Wattana et al., 2007). This decline further demonstrates the 
inadequacy of the existing national sentinel surveillance system which is based on sampling 
PWID at public methadone clinics.
In our survey, PWID in Chiang Mai appear more likely to have been recently infected; HIV 
prevalence among young participants, a proxy measure of incidence, was twice as high in 
Chiang Mai compared to Bangkok. Chiang Mai participants were also more likely to be new 
injectors and to have shared needles. HIV infection in Chiang Mai was also clearly 
associated with recent injecting behavior, including the injection of a range of drug classes; 
methamphetamine, methadone, and particularly midazolam. Our finding that recent injecting 
midazolam use was independently associated with HIV infection in Chiang Mai is 
particularly important given reports of increasing midazolam injecting use in Thailand and 
the numerous health-related harms associated with its use including needle-sharing, 
overdose and injecting-related health problems (Hayashi et al., 2012; Kerr et al., 2010). 
Hayashi and colleagues found that in Bangkok midazolam use was associated with femoral 
vein injection and various risk factors for injected-related complications (Hayashi et al., 
2012). Given that injecting midazolam use levels are still relatively low and emerging in 
Chiang Mai, a lack of knowledge and skills about how to inject safely may have increased 
HIV transmission risk compared to PWID where injectors are older and more experienced. 
In Bangkok, we corroborated the results of other studies that have found high levels of 
midazolam injecting use (Hayashi et al., 2012; Kerr et al., 2010; van Griensven et al., 2005; 
Werb et al., 2009). Midazolam distribution is focused in Bangkok and it is a cheaper and 
more accessible substitute for heroin, especially as heroin has become less available and 
more expensive (Kerr et al., 2010). There is an urgent need more research on this rapidly 
emerging problem. For example, it will be important to learn more about the injecting 
practices that may be leading to increased HIV and other blood-borne infection transmission 
(e.g., is femoral artery injection) to rapidly inform the implementation of customized 
educational and harm reduction interventions as part of a comprehensive combination 
prevention strategy.
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While patterns of if injecting drug use were different in Bangkok and Chiang Mai, 
methamphetamine was the most commonly reported injecting drug in both cities. In 
Bangkok our results corroborate results from other studies in showing an increasing trend of 
methamphetamine use and decreasing heroin use (Hayashi et al., 2011; Kerr et al., 2010; 
Martin et al., 2010, 2011; Poshyachinda et al., 2005; van Griensven et al., 2005; Wattana et 
al., 2007; Werb et al., 2009). In Chiang Mai our results extend earlier findings of what was 
previously an emerging epidemic of mainly non-injecting methamphetamine use among 
young users with elevated levels of high risk sexual activity (Beyrer et al., 2004). Thailand 
has consistently been one of the leading countries for methamphetamine seizures, reporting 
the equivalent of ten million tons in 2012 (UNODC, 2014) and there is a strong need for 
clear and strategic policy recommendations on how to address the health-related harms 
among these injectors who are not traditionally served by the drop in centers that were 
designed in the past for heroin injectors. Our study findings also show that methadone 
injection was also higher in Bangkok than Chiang Mai. Methadone-based treatment sites in 
Thailand are concentrated in Bangkok but more research is needed here as few studies have 
reported on its non-therapeutic use. On the other hand, opium injection was more common 
in Chiang Mai, which is consistent with opium production and distribution being focused in 
Northern Thailand (Razak et al., 2003).
The low rates of needle sharing (14.5%) found in our Bangkok survey are similar to results 
reported previously (Wattana et al., 2007) and support a generally observed trend of lower 
needle sharing over time compared with 1994–1999 in Bangkok, when this figure was one-
third or higher (Choopanya et al., 2013; Martin et al., 2010, 2011; Pitisuttithum et al., 2006; 
van Griensven et al., 2005; Vanichseni et al., 2001). On the other hand, in Chiang Mai we 
found that an alarming two-thirds of participants reported recent needle sharing, which is 
likely a reflection of their young age, recent initiation into drug injection practice, and lack 
of intervention programs available.
In our Bangkok survey, the prevalence of reported sex with multiple sex partners was 
similar to results from other studies in Bangkok (Choopanya et al., 2013; Martin et al., 2010, 
2011). In Chiang Mai, we found high levels of sexual risk behavior, which is not surprising 
given the young age of PWID there and the low availability of HIV prevention interventions 
in the area. Most worrisome was the finding that one-third of PWID in Chiang Mai reported 
having at least one sexual partner who also injected drugs. Such high levels of overlapping 
risk behaviors at young ages are a volatile combination and could potentiate further HIV 
transmission to broader populations without expanded coverage of education and service 
delivery interventions for PWID. We found that nearly identical proportions of male 
participants in our Bangkok study and the Bangkok Tenofovir Study (Choopanya et al., 
2013) reported having recent sex with a male partner (4–5%). In our Chiang Mai survey, this 
proportion was over twice as high. While we did not find recent sexual risk behaviors to be 
associated with HIV infection it will be important to monitor trends and patterns closely. 
Currently there is an HIV epidemic among men who have sex with men (MSM) in Thailand 
and monitoring MSM behavior should be incorporated as part of PWID surveillance (van 
Griensven et al., 2010).
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Our surveys had a number of limitations. First, we cannot verify that all participants met the 
study inclusion criteria and it is possible that non-PWID participated because of the financial 
compensation available to participants. To reduce the possibility of recruiting non-eligible 
persons, we trained staff to ask participants to show injection marks and administered a 
comprehensive list of screening questions. Second, many findings were based on self-
reported responses given by participants and was potentially subject to social desirability 
bias. However, interviewers were trained to make participants feel comfortable during the 
interview process and the high levels of sensitive risk behaviors disclosed suggest that this 
was not a major source of bias. Third, our survey results may not be generalizable to all 
PWID in Bangkok and Chiang Mai, respectively. Some PWID in both cities may not be 
socially networked or may have chosen not to participate due to the travel distance, fear that 
they might be arrested by the police, or a lack of confidence about the confidentiality of their 
personal information. Fourth, participants in Bangkok were recruited from a peer-based 
drop-in center while Chiang Mai participants were recruited from a research institute and 
this may have introduced participant selection bias. However, we believe our study findings 
in both sites are valid, in that the diverse seeds selected at both RDS sites were effective in 
recruiting peers and the multiple measurable assumptions were met in the RDSAT-based 
analysis (i.e., equilibrium was reached, sufficient waves of recruitment were reached, 
homophily was within expected limits; Salganick and Heckathorn, 2004; Volz and 
Heckathorn, 2008).
In conclusion, our findings show that PWID epidemics in Thailand are heterogeneous and 
driven by local factors. This geographical variation has also been found in other countries in 
the region (Degenhardt et al., 2010a) and means that a ‘one size fits all’ approach to the 
PWID epidemic in Thailand is likely to be ineffective. Given the diverse and high levels of 
polydrug injecting use documented it is recommended that a comprehensive and integrated 
combination intervention approach is developed. This is because no one specific 
intervention strategy encompasses all known HIV risk factors. An evidence-based 
systematic review of intervention strategies pointed to the need for combination approaches 
that combine individual and structural combination HIV prevention approaches with needle 
and syringe programs, opioid substitution treatment and antiretroviral treatment as 
approaches with the greatest potential effect (Degenhardt et al., 2010b). However, the high 
and growing prevalence of non-opioid injecting drug use in Thailand requires integration of 
novel approaches. For example, the recently concluded Bangkok Tenofovir Study (BTS), a 
randomized placebo-controlled double-bind trial, has shown that daily pre-exposure 
prophylaxis (PrEP) with tenofovir reduced the risk of HIV infection among PWID 
(Choopanya et al., 2013; Martin et al., 2011). Based on these results, PrEP should be 
considered as important additional strategic tool as part of a comprehensive package of 
effective HIV prevention interventions, particularly among PWID practicing high-risk 
behaviors.
At present, no approved pharmaocotherapies are available for methamphetamine or other 
amphetamine-type stimulants and the predominant treatment approach remains limited to 
psychosocial approaches. The Bangkok Metropolitan Administration and MOPH are now 
implementing the MATRIX program for methamphetamine dependence that includes 
components such as recovery skills, relapse prevention and family education. As these 
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services are further expanded, it is increasingly important that HIV prevention, care and 
treatment services are tightly integrated with drug treatment programs throughout Thailand. 
This scale-up will require close and rigorous monitoring of service quality such and the 
ongoing training of drug treatment service providers. Since our surveys were reported, the 
MOPH has begun conducting RDS surveys in additional geographical areas as part of 
routine surveillance and as a method to evaluate planned and ongoing intervention service 
packages targeting PWID.
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